chr11-56105202-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001386064.1(OR8H2):c.160C>A(p.Leu54Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386064.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR8H2 | NM_001386064.1 | c.160C>A | p.Leu54Ile | missense_variant | 2/2 | ENST00000313503.2 | NP_001372993.1 | |
OR8H2 | NM_001005200.2 | c.160C>A | p.Leu54Ile | missense_variant | 2/2 | NP_001005200.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR8H2 | ENST00000313503.2 | c.160C>A | p.Leu54Ile | missense_variant | 2/2 | 6 | NM_001386064.1 | ENSP00000323982.1 | ||
OR8H2 | ENST00000641311.1 | c.160C>A | p.Leu54Ile | missense_variant | 2/2 | ENSP00000493031.1 | ||||
OR8H2 | ENST00000618136.1 | c.157C>A | p.Leu53Ile | missense_variant | 1/1 | 6 | ENSP00000482661.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251438Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135888
GnomAD4 exome AF: 0.000181 AC: 265AN: 1461874Hom.: 0 Cov.: 34 AF XY: 0.000173 AC XY: 126AN XY: 727236
GnomAD4 genome AF: 0.000105 AC: 16AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 28, 2024 | The c.160C>A (p.L54I) alteration is located in exon 1 (coding exon 1) of the OR8H2 gene. This alteration results from a C to A substitution at nucleotide position 160, causing the leucine (L) at amino acid position 54 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at